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The effects of all-trans retinoic acid on the differenti-
ation and proliferation of immature melanocyte pre-
cursors were studied. NCC-melb4 cells are an
immortal cloned cell line established from mouse
neural crest cells using a single-cell cloning method.
These cells were positive for tyrosinase-related
protein 1, tyrosinase-related protein 2 and KIT, but
were negative for tyrosinase and had no dihydroxy-
phenylalanine reaction. They contained only stage I
melanosomes without any melanosomes in more
advanced stages. After treatment with all-trans
retinoic acid, many of the cells became tyrosinase-
and dihydroxyphenylalanine-reaction-positive, chan-
ged from polygonal to dendritic in shape, and had
stage III to IV melanosomes. These ®ndings indicate
that treatment with all-trans retinoic acid induced the
differentiation of NCC-melb4 cells. Reverse tran-
scription polymerase chain reaction analysis revealed
a marked increase in expression of microphthalmia-
associated transcription factor mRNA after all-trans
retinoic acid treatment, suggesting that microphthal-
mia-associated transcription factor may be the key
molecule in this event. Enhanced expression of
protein kinase Ca following treatment with all-trans
retinoic acid was also demonstrated. The prolifer-
ation of NCC-melb4 cells was inhibited by all-trans
retinoic acid in a dose-dependent manner. Increased
apoptosis after all-trans retinoic acid treatment was
observed by electron microscopy, the TUNEL
method, DNA fragmentation assay, and ¯ow cyto-
metry. All-trans retinoic acid upregulated caspase-3
and downregulated bcl-2. Electron microscopy
showed that apoptotic cells contained melanosomes
of advanced stages, suggesting that mature melano-
cytes may tend to undergo apoptosis after all-trans
retinoic acid treatment. This study provides import-
ant clues towards understanding the roles and work-
ing mechanisms of retinoic acids in melanocyte
development and melanogenesis. Key words: bcl-2,
caspase-3, melanogenesis, protein kinase Ca/retinoic acid. J
Invest Dermatol 118:35±42, 2002
R
etinoids, a group of chemically related molecules
derived from vitamin A, regulate a large number of
biologic processes in vertebrate development, cell
growth, differentiation, and homeostasis (De Luca,
1991; Tabin, 1991). These effects are thought to be
mediated by nuclear receptors that belong to the superfamily of
steroid/thyroid hormone receptors. There are two major classes of
retinoid nuclear receptors, the retinoic acid (RA) receptors (RAR)
and the retinoid X receptors (RXR). The RAR binds all-trans
retinoic acid (ATRA) and 9-cis retinoic acid (9-cis RA), whereas
the RXR binds only 9-cis RA (Levin et al, 1992; Allenby et al,
1993). There are three subtypes (a, b, and g) of each RAR
(Giguere et al, 1987; Petkovich et al, 1987) and RXR (Mangelsdorf
et al, 1990; Hoopes et al, 1992). These receptors are retinoid-
activated transcription factors that act by binding to speci®c DNA
sequences termed retinoic acid response elements (De The et al,
1989; Umesono et al, 1991).
RA has been shown to induce differentiation and/or inhibit
proliferation of many different types of tumor cells (De Luca,
1991), including a variety of melanoma cell lines (Lotan et al, 1978;
Ludwig et al, 1980; Meyskens and Fuller, 1980). The growth
inhibition of B16 mouse melanoma cells by ATRA was associated
with an increase in protein kinase C (PKC) activity (Niles and
Loewy, 1989). Overexpression of PKCa in B16 melanoma cells
resulted in longer doubling times, diminished anchorage-inde-
pendent growth, and increased melanin production, suggesting that
PKCa may be one of the key molecules involved in RA-induced
melanoma differentiation (Gruber et al, 1992). These ®ndings
strongly suggest a possible role of RA in melanocyte development
and melanogenesis, but little is known concerning the effect of RA
on the growth and differentiation of melanocytes or melanocyte
precursors.
We have established an immortal cell population of neural crest
cells (NCC) from WB mice, and designated them as NCC-S4.1
cells (Kawa et al, 2000). From the NCC-S4.1 cells, we cloned a cell
line named NCC-melb4 cells using a single-cell cloning method.
NCC-melb4 cells are immortal and stable in culture medium
supplemented with stem cell factor (SCF), and measurement of
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their DNA content indicated that they retain normal DNA ploidy
without malignant transformation (Ito et al, manuscript in prepar-
ation). They appear to be immature melanocytes, as they are
positive for some of the marker molecules for melanocytes, but are
negative for tyrosinase and dihydroxyphenylalanine (DOPA)
reaction. Using this NCC-melb4 cell line, we have now investi-
gated the effect of ATRA on the differentiation and proliferation of
immature melanocyte precursors.
MATERIALS AND METHODS
Cells and culture conditions NCC-melb4 cells were established using
a single-cell cloning method from an immortal cell population (NCC-
S4.1) established from NCC of WB Sl/+ or +/+ mice (Kawa et al,
2000). The cells were grown in a humidi®ed atmosphere of 5% CO2
and 95% air at 37°C in Eagle's modi®ed essential medium supplemented
with 5% fetal bovine serum (Gibco/BRL, Grand Island, NY) and 50 ng
per ml of recombinant mouse SCF (Kirin Brewery, Tokyo, Japan).
ATRA (Biomol Research Laboratories, Plymouth Meeting, PA) was
dissolved in ethanol at a concentration of 10±2 M as a stock solution, and
then was added to the cell cultures at a ®nal concentration of 10±6 M,
unless indicated otherwise. Cells treated with ATRA for 72 h were used
in this study.
Immunohistochemistry, DOPA reaction, and electron
microscopy The monoclonal antibody to mouse KIT (ACK2), which
was generated as described previously (Nishikawa et al, 1991), was a
generous gift from Dr. Nishikawa (Kyoto University, Kyoto, Japan).
Antibodies to tyrosinase (aPEP7, carboxy terminus of tyrosinase),
tyrosinase-related protein 1 (TYRP1) (aPEP1, carboxy terminus of
TYRP1), and tyrosinase-related protein 2 (TYRP2) (aPEP8, carboxy
terminus of TYRP2) were prepared as described previously (Jimenez et
al, 1991; Tsukamoto et al, 1992) and kindly supplied by Dr. Hearing
(NIH, Bethesda, MD). The cells were ®xed with 95% ethanol at room
temperature and treated with anti-mouse KIT (ACK2), tyrosinase,
TYRP1, TYRP2, or endothelin B receptor (EDNRB) antibody (IBL,
Maebashi, Japan) as described previously (Kawa et al, 2000). For caspase-
3 staining, cells were treated with anti-caspase-3 antibody (R&D
Systems, Minneapolis, MN). They were then reacted with alkaline-
phosphatase-labeled antirat IgG (Southern Biotechnology, Birmingham,
LA) or rabbit IgG (Dako, Carpinteria, CA) and developed using the
New Fuchsin Substrate System (Dako). DOPA reaction, electron
microscopy, and electron microscopic DOPA staining were performed as
described elsewhere (Kawa et al, 2000).
RNA extraction and reverse transcription polymerase chain
reaction (RT-PCR) analysis Total RNA was extracted from the
cells using an RNA isolation kit (Qiagen, Hilden, Germany) as described
by the manufacturer. cDNA was prepared from 10 mg total RNA using
MMLV Reverse Transcriptase (Gibco/BRL, Gaithersburg, MD). PCRs
consisted of 34 cycles for tyrosinase and microphthalmia-associated
transcription factor (MITF) or 35 cycles for RAR and PKC (Oxford
Biomedical Research, Oxford, MI). PCRs were initiated with a ``cold
start'', followed by denaturation at 98°C for 10 s (tyrosinase and MITF)
or at 94°C for 45 s (RAR) or at 94°C for 60 s (PKC), annealing at
60°C for 30 s (tyrosinase and MITF) or at 50°C for 30 s (RAR) or at
55°C for 60 s (PKC), and polymerization at 72°C for 60 s (tyrosinase
and MITF) or at 72°C for 90 s (RAR) or at 72°C for 60 s (PKC). The
primer sequences used were as follows: tyrosinase sense primer 5¢-
CTATGTCATCCCCACAGGCAC-3¢; tyrosinase antisense primer 5¢-
TTACCTGCCAGGAGGAGAAGA-3¢; MITF sense primer 5¢-AGT-
CACTACCAGGTGCAGAC-3¢; MITF antisense primer 5¢-CTTGC-
TTCAGACTCTGTGGG-3¢; RARa sense primer 5¢-CAGATGC-
ACAACGCTGGC-3¢; RARa antisense primer 5¢-CCGACTGTCC-
GCTTAGAG-3¢; RARb sense primer 5¢-ATGCTGGCTTCGGTC-
CTC-3¢; RARb antisense primer 5¢-CTGCAGCAGTGGTGACTG-3¢;
RARg sense primer 5¢-GTGGAGACCGAATGGACC-3¢; RARg
antisense primer 5¢-GACAGGGATGAACACAGG-3¢; PKC (Oxford);
b-actin (Promega, Madison, WI).
Figure 1. Immunostaining and DOPA
reaction of NCC-melb4 cells. Cells were
cultured on cover glasses in six-well plates and
were immunohistochemically stained as described
in Materials and Methods. The cells were positive
for TYRP1 (a), TYRP2 (b), and KIT (c), but
were negative for EDNRB (d), tyrosinase (e), and
DOPA reaction (f). Scale bar: 10 mm.
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PCR products were resolved in 2% agarose gels containing ethidium
bromide in parallel with DNA molecular weight markers.
Protein isolation and Western blot analysis Cells were harvested by
scraping, collected by centrifugation, and then lyzed in cell lysis buffer
(1% Triton X-100, 10 mM Tris±HCl, pH 7.4). Cell lysates were run on
10% sodium dodecyl sulfate (SDS) polyacrylamide gel. After
electrophoresis, peptides on the gel were electroblotted onto
nitrocellulose ®lters and the ®lters were incubated for 2 h in Tris-
buffered saline (100 mM NaCl, 50 mM Tris±HCl, pH 7.4) containing
2.5 mg per ml of non-fat powdered milk (TBS-milk). The ®lters were
then incubated overnight in the presence of anti-PKCa antibody
(1:10,000) (Sigma, St. Louis, MO) or anti-bcl-2 antibody (1:20)
(Oncogene, Cambridge, MA) and reacted with alkaline-phosphatase-
labeled antirabbit IgG (Dako) for 90 min. The ®lters were washed in
TBS-milk and the antigens were detected with 5-bromo-4-chloro-3-
indolyl phosphate (Sigma) and nitroblue tetrazodium (Sigma).
Proliferation assay Cells were plated at 2000 cells per well in 96-well
plates. On the next day various concentrations of ATRA (10-4±10-8 M)
were added to the culture medium (day 0). On days 0, 2, and 5, they
were incubated with alamar Blue (Trek Diagnostic Systems, Westlake,
OH) for 4 h and the ¯uorescence was read on a Fluoroskan II
microplate reader (Labsystems, Helsinki, Finland).
Apoptosis assay For the detection of apoptotic cells, cells were stained
with the Apop Tag in situ apoptosis detection kit (Oncor, Gaithersburg,
MD) as described by the manufacturer. The Apop Tag kit is a
modi®cation of the TUNEL (Tdt-mediated d-UTP nick end labeling)
method that can detect DNA fragments caused by apoptosis. For DNA
fragmentation assay, the cells were harvested by scraping, collected by
centrifugation, and then analyzed with Apoptosis Ladder Detection kit
(Wako, Osaka, Japan), as described previously (Ito et al, 1999).
Fluorescence-activated cell sorter analysis Analysis of
phosphatidylserine on the lea¯et of apoptotic cell membranes was
performed using an Annexin V ¯uorescence isothiocyanate (FITC) kit
(Immunoteck, Marseilles, France). Double staining for FITC-Annexin V
binding and for cellular DNA using propidium iodide (PI) was
performed as follows. FITC-Annexin V was added to a ®nal
concentration of 1 mg per ml Annexin V and PI was added to a ®nal
concentration of 1 mg per ml. The mixture was incubated for 15 min in
the dark at room temperature and was then measured by ¯ow cytometry
(FACScan, Becton Dickinson, Mountain View, CA) using program
Lysys 2 (Vermes et al, 1995). This assay enables us to discriminate intact
cells (FITC±/PI±), early apoptotic cells (FITC+/PI±), and late apoptotic
cells or necrotic cells (FITC+/PI+).
Statistical analysis Student's t test was used for statistical analysis.
RESULTS
Characterization of NCC-melb4 cells NCC-melb4 cells
were stained immunohistochemically to determine their
phenotype and stage of differentiation (Fig 1). The cells were
positive for TYRP1, TYRP2, and KIT, but were negative for
tyrosinase and did not react with DOPA. They were also negative
for EDNRB. These ®ndings indicate that NCC-melb4 cells are not
Figure 2. RT-PCR analysis for RAR mRNA expression in NCC-
melb4 cells. Total RNA was reverse transcribed followed by 35 PCR
cycles of cDNA using the primers described in Materials and Methods.
Lane 1, b-actin; lane 2, RARa; lane 3, RARb; lane 4, RARg.
Figure 3. Effects of ATRA on tyrosinase
expression and DOPA reaction. NCC-melb4
cells treated with ATRA for 72 h were
immunostained for tyrosinase (a) and were tested
for DOPA reaction (b). Scale bar: 10 mm. (c) Total
RNA extracted from the cells treated with or
without ATRA for 72 h was reverse transcribed
followed by 34 PCR cycles of cDNA using the
primers described in Materials and Methods. Lanes 1,
2, b-actin; lanes 3, 4, tyrosinase.
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mature melanocytes but are immature melanocyte precursors. RT-
PCR analysis revealed that RARa, RARb, and RARg mRNA
were expressed in the cells (Fig 2).
Differentiation of NCC-melb4 cells induced by ATRA We
investigated the effects of ATRA on the differentiation of NCC-
melb4 cells. As noted above, before the treatment with ATRA, the
cells were negative for tyrosinase and DOPA reaction but, after
72 h of ATRA treatment, many of the cells became tyrosinase and
DOPA reaction positive (Figs 3a, b). RT-PCR analysis showed
enhanced expression of tyrosinase mRNA after 72 h of ATRA
treatment (Fig 3c). Accompanying these changes, the cells
dramatically altered their morphology: they changed from
polygonal in shape to bipolar or dendritic (Fig 4). Electron
microscopy and electron microscopic DOPA staining are shown in
Fig 5. Before treatment with ATRA, the cells contained stage I
melanosomes without any in more advanced stages, and were
DOPA negative. After 72 h of ATRA treatment, stage III to IV
melanosomes became apparent, and positive DOPA staining was
demonstrated in the Golgi areas and in melanosomes. The sum of
these ®ndings strongly suggests that ATRA stimulates the
differentiation of NCC-melb4 cells.
Induction of MITF and PKCa by treatment with
ATRA To further investigate the molecular basis of
melanocyte differentiation induced by ATRA, we tested mRNA
expression of MITF and PKC. NCC-melb4 cells were incubated
with or without ATRA for 72 h, and then total RNA was
extracted and analyzed by RT-PCR. As shown in Fig 6(a), a
marked induction of MITF mRNA was demonstrated following
treatment with ATRA, suggesting that this transcription factor may
be the key molecule in this event. Enhanced expression of PKCa
Figure 4. Morphologic changes after ATRA
treatment. Phase-contrast photomicrographs of
NCC-melb4 cells were made before (a) and after
(b) 72 h of treatment with ATRA. Scale bar:
40 mm.
Figure 5. Electron microscopy and electron
microscopic DOPA staining of NCC-melb4
cells. (a) Electron microscopy before ATRA
treatment. Arrows indicate stage I melanosomes. (b)
Electron microscopic DOPA staining before
ATRA treatment showing negative DOPA
reaction. (c) Electron microscopy after 72 h of
ATRA treatment showing stage III to IV
melanosomes in the cytoplasm (arrows). (d)
Electron microscopic DOPA staining after 72 h of
ATRA treatment showing positive reactions in
the Golgi areas and in melanosomes. Scale bar:
1 mm.
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mRNA, but not of PKCb mRNA, was also demonstrated in the
ATRA-treated cells (Fig 6b). Western blot analysis revealed an
increase in PKCa after 72 h of ATRA treatment (Fig 6c).
Inhibitory effects of ATRA on cell proliferation is associated
with increased apoptosis Next we investigated the effect of
ATRA on the proliferation of NCC-melb4 cells. As shown in
Fig 7, ATRA inhibited cell proliferation in a dose-dependent
manner. Cells incubated with ATRA for 72 h were observed by
electron microscopy (Fig 8). Some cells had condensed nuclei with
homogeneous and compacted chromatin, which are characteristics
of apoptotic cells, and interestingly the majority of melanosomes in
the apoptotic cells were mature melanosomes. As these ®ndings
suggested that growth inhibition by ATRA might be associated
with increased apoptosis, we performed the Apop Tag in situ
apoptosis detection assay. As shown in Fig 9(a, b), incubation of
cells with ATRA for 72 h resulted in an increased number of
apoptotic cells. We also analyzed genomic DNA extracted from the
Figure 6. Induction of MITF and PKCa by ATRA treatment.
RT-PCR analysis of MITF (a) and PKCa (b) mRNA from NCC-melb4
cells treated with or without ATRA for 72 h. (a) Lanes 1, 2, b-actin;
lanes 3, 4, MITF. (b) Lanes 1, 2, b-actin; lanes 3, 4, PKCa; lanes 5, 6,
PKCb. (c) Western blot analysis of PKCa from the cells treated with or
without ATRA for 72 h.
Figure 7. Growth inhibition by ATRA.
NCC-melb4 cells were plated at 2000 cells per
well in 96-well plates and were incubated with (a)
SCF (h), SCF + 10±6 M ATRA (e), or SCF +
vehicle (s); (b) SCF + various concentrations of
ATRA. On days 0, 2, and 5 (a) and on day 5 (b),
cells were incubated with alamar BlueTM and the
¯uorescence was read on a Fluoroskan II
microplate reader. Values are means 6 SD of six
determinations. *p < 0.05; **p < 0.01.
Figure 8. Electron microscopy ®ndings of apoptotic cells after
ATRA treatment. Apoptotic cells with scattered fragments of
condensed nuclei (closed arrow) contained melanosomes at advanced stages
(open arrows). Scale bar: 1 mm.
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cells with or without ATRA for 72 h. DNA from the ATRA-
treated cells exhibited a ladder-like pattern of oligonucleosome-
sized DNA fragments characteristic of apoptosis (Fig 9c).
Figure 10 shows the results of FITC-Annexin V/PI ¯ow
cytometry of NCC-melb4 cells incubated with or without
ATRA for 1, 3, and 5 d. The experiments were repeated three
times, and the average 6 SD of the FITC+/PI± cell population,
which represents apoptotic cells, was calculated. One day of
treatment with ATRA did not cause a signi®cant increase in
apoptosis. After 3 d of ATRA treatment, the apoptotic cell
population was signi®cantly increased (10.53% 6 0.75%)
compared with the untreated controls (5.29% 6 0.42%,
p < 0.01). After 5 d, the apoptotic cell population was still larger
(4.15% 6 0.30%) in ATRA-treated cells than in untreated cells
(2.19% 6 0.10%, p < 0.01).
Altered expression of caspase-3 and bcl-2 after ATRA
treatment To con®rm the involvement of apoptosis in
ATRA-induced growth inhibition, we investigated the effect of
ATRA on two apoptosis-related molecules: caspase-3 and bcl-2.
On immunostaining, a marked increase in caspase-3-positive cells
was demonstrated after 72 h of ATRA treatment (Fig 11). Western
blot analysis revealed a decrease in bcl-2 after 72 h of ATRA
treatment (Fig 12). These ®ndings seem to provide additional
evidence that apoptosis is involved in ATRA-induced growth
inhibition of NCC-melb4 cells.
DISCUSSION
Various factors, including SCF, endothelin 3, 12-O-tetradecanoyl-
phorbol-13-acetate, and cholera toxin have been shown to
Figure 9. Increased apoptosis after ATRA treatment. NCC-melb4 cells before (a) and after (b) 72 h of ATRA treatment were stained with the
Apop Tag in situ apoptosis detection kit. Scale bar: 20 mm. (c) DNA fragmentation assay. Agarose gel electrophoresis was used to detect
internucleosomal DNA cleavage in NCC-melb4 cells with or without ATRA for 72 h. Lane 1, control; lane 2, ATRA-treated cells; lane 3, ladder
marker.
Figure 10. Flow cytometric analysis of
ATRA-treated cells. Contour diagram of FITC-
Annexin V/PI ¯ow cytometry of the cells
incubated with ATRA (d, e, f) or vehicle alone (a,
b, c) for 1 d (a, d), 3 d (b, e), and 5 d (c, f). The
lower left quadrants of the panels show the viable
cells, which exclude PI and are negative for
FITC-Annexin V binding. The upper right
quadrants contain the nonviable, late apoptotic
cells or necrotic cells, positive for FITC-Annexin
V binding and for PI uptake. The lower right
quadrants represent the early apoptotic cells,
which are FITC-Annexin V positive and PI
negative, demonstrating cytoplasmic membrane
integrity. This diagram is representative of three
separate experiments with similar results.
40 WATABE ET AL THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
stimulate the differentiation of melanocyte precursors (Murphy et
al, 1992; Ito et al, 1993; Ono et al, 1998), but the effect of RA on
the differentiation of melanocyte precursors has not yet been
established. NCC-melb4 cells were cloned from murine NCC in
our laboratory and were immortal and stable in culture medium
supplemented with SCF. As they expressed several melanocyte-
speci®c markers (TYRP1, TYRP2, and KIT) but were negative for
tyrosinase and did not produce melanin, NCC-melb4 cells were
thought to be immature melanocyte precursors. In this study, we
showed that NCC-melb4 cells treated with ATRA became
tyrosinase and DOPA reaction positive, changed in shape from
polygonal to dendritic, and contained melanosomes at advanced
stages. These ®ndings indicate that ATRA promotes the differen-
tiation of melanocyte precursors, and also suggest a possible role for
RA in melanocyte development in vivo.
In melanoma cells, differentiation induced by ATRA is closely
associated with enhanced expression of PKCa (Gruber et al, 1992;
1995). In our experiments using NCC-melb4 cells, induction of
PKCa mRNA and protein by ATRA was also observed. Thus,
PKCa seems to be commonly involved in the biologic effects of
ATRA in melanoma cells and in melanocyte precursors.
MITF is the human homolog of the mouse microphthalmia (mi)
gene product, which was identi®ed as a novel transcription factor of
the basic helix±loop±helix (bHLH) leucine zipper protein family
(Hodgkinson et al, 1993; Hughes et al, 1993; Tachibana et al, 1994).
MITF is able to direct melanocyte-speci®c transcription of the
tyrosinase and TYRP1 genes (Yasumoto et al, 1994, 1997) and is
thought to be involved in the differentiation and maintenance of
melanocytes (Tachibana, 1997, 2000). As tyrosinase expression is
upregulated by ATRA it was of interest to determine whether
ATRA alters MITF expression in NCC-melb4 cells. RT-PCR
analysis revealed that MITF mRNA expression was markedly
increased by ATRA treatment, which suggests that MITF, as well
as PKCa, may be the key factor in ATRA-induced melanocyte
differentiation. This is the ®rst study showing the induction of
MITF by treatment with ATRA.
We also showed that ATRA inhibited the proliferation of NCC-
melb4 cells and induced apoptosis. Apoptosis is a distinctive form of
cell death that can result in the deletion of speci®c cell populations
during physiologic processes such as embryonal development and
the clonal selection of lymphocytes (Kerr et al, 1972; Wyllie et al,
1980). Several methods have been developed to detect apoptosis.
The nick end labeling method of DNA fragments achieved by the
TUNEL method, morphologic observations by electron micro-
scope, gel electrophoresis of genomic DNA ladder-like fragments,
and ¯ow cytometry of FITC-Annexin V/PI (Vermes et al, 1995)
are generally recognized and adopted as diagnostic bases for
apoptosis. Fragmentation occurs in each unit of nucleosome in
chromatin DNA during apoptosis. After the cleaving of a large
fragment of 50±200 kbp, oligonucleosome size (= 180 bp) frag-
mentation occurs (Brown et al, 1993). In this study, we demon-
strated that apoptosis was increased following treatment with
ATRA using electron microscopy, the TUNEL method, DNA
fragmentation assay, and ¯ow cytometry.
Caspases have been implicated in the execution phase of
apoptosis (Nicholson and Thornberry, 1997) and are shown to
cleave speci®c substrates as the cell begins to present the
characteristic morphologic changes of apoptosis. Caspase-3 was
shown to cleave a wide range of cytoplasmic and nuclear proteins,
which suggests an important role for this protease in apoptosis
(Germain et al, 1999). In this study, we showed a marked increase
in caspase-3-positive cells after ATRA treatment. Bcl-2 has been
shown to prolong cell survival and block apoptosis (Reed, 1994).
Western blot analysis revealed that bcl-2 expression was markedly
decreased by ATRA treatment. These ®ndings seem to provide
additional evidence for the involvement of apoptosis in ATRA-
induced growth inhibition of NCC-melb4 cells.
Figure 11. Induction of caspase-3 by ATRA
treatment. NCC-melb4 cells treated with (b) or
without (a) ATRA for 72 h were immunostained
for caspase-3 as described in Materials and Methods.
Scale bar: 20 mm.
Figure 12. Decreased expression of bcl-2 after ATRA treatment.
NCC-melb4 cells treated with or without ATRA for 72 h were
analyzed by Western blotting for their expression of bcl-2.
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The observation that many of the apoptotic cells contained
mature melanosomes in their cytoplasm may indicate that mature
and differentiated melanocytes apoptose after ATRA treatment.
Therefore it is conceivable that ATRA has bifunctional effects on
melanocytes: it may stimulate the differentiation of melanocyte
precursors by inducing tyrosinase, and it may remove terminally
differentiated melanocytes through apoptosis. Regarding the effect
of RA on melanogenesis, con¯icting data have been published.
Melanogenesis in melanoma cells can be modulated positively or
negatively by RA (Lotan and Lotan, 1980; Edward et al, 1988;
Orlow et al, 1990). In vivo studies have revealed that topical
application of RA can stimulate melanin production in mice (Ho et
al, 1992; Welsh et al, 1999) and in humans (Talwar et al, 1993), but,
in contrast, several clinical studies have shown that topical
application of RA can improve hyperpigmented skin lesions
(Rafal et al, 1992; Bulengo-Ransby et al, 1993; Grif®ths et al, 1993).
The bifunctional effects of ATRA suggested by our study provide
clues to interpret these apparently contradictory ®ndings; thus,
ATRA may stimulate melanogenesis by inducing melanocyte
differentiation, and may at the same time inhibit melanogenesis by
removing mature melanocytes through apoptosis. The ®ndings
reported in this study provide some important viewpoints to
understand the roles and working mechanisms of RA in
melanocyte development and melanogenesis.
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